IWM ETF Factor Report

Validea's fundamental report on the iShares Russell 2000 ETF (IWM), a Mid-Cap Value ETF, highlights its factor exposures and portfolio composition. The ETF, heavily weighted in Services and Biotechnology & Drugs, scores 56 for Value and 53 for Momentum, but notably low at 7 for Quality and 13 for Low Volatility, indicating a fundamental profile skewed towards higher risk and lower quality characteristics within the small-cap segment.

Analysis

Based on Validea's fundamental report, the iShares Russell 2000 ETF (IWM) presents a distinct factor profile for a Mid-Cap Value ETF. While it scores moderately on Value (56) and Momentum (53), its exposure to Quality (7) and Low Volatility (13) is exceptionally low. This quantitative profile indicates that the underlying portfolio, which has its largest concentrations in the Services sector and the Biotechnology & Drugs industry, is composed of companies that may be inexpensive and have recent price appreciation but lack indicators of fundamental strength such as stable profitability or strong balance sheets. The combination of low quality and low volatility scores, particularly with a heavy weighting in the often-speculative biotech industry, points to a higher-risk, higher-beta constitution for the small-cap segment it represents.

Key Decisions for Investors

• Investors should recognize that IWM's composition carries a significant risk profile, characterized by extremely low exposure to Quality and Low Volatility factors, making it potentially unsuitable for conservative or risk-averse strategies.
• For portfolios seeking specific factor tilts, IWM offers moderate access to Value and Momentum, but those prioritizing fundamental strength and stability should consider alternative small-cap ETFs or hedge this exposure accordingly.
• The ETF's performance is likely sensitive to sentiment in the Biotechnology sector given its status as the largest industry holding; therefore, investors should monitor industry-specific catalysts and risk appetite for speculative growth assets.